CannBioRx Non Current Assets Total from 2010 to 2024

ATNFW Stock  USD 0.01  0  22.64%   
CannBioRx Life Non Current Assets Total yearly trend continues to be fairly stable with very little volatility. Non Current Assets Total will likely drop to about 1.5 M in 2024. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2017-06-30
Previous Quarter
1.6 M
Current Value
9.2 M
Quarterly Volatility
41.9 M
 
Covid
Check CannBioRx Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannBioRx Life's main balance sheet or income statement drivers, such as Interest Expense of 42.59, Selling General Administrative of 7.6 M or Interest Income of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. CannBioRx financial statements analysis is a perfect complement when working with CannBioRx Life Valuation or Volatility modules.
  
Check out the analysis of CannBioRx Life Correlation against competitors.

Latest CannBioRx Life's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of CannBioRx Life Sciences over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. CannBioRx Life's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CannBioRx Life's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

CannBioRx Non Current Assets Total Regression Statistics

Arithmetic Mean81,261,151
Geometric Mean47,607,429
Coefficient Of Variation58.55
Mean Deviation42,602,630
Median116,588,017
Standard Deviation47,582,444
Sample Variance2264.1T
Range116.6M
R-Value(0.88)
Mean Square Error567.8T
R-Squared0.77
Significance0.000019
Slope(9,319,013)
Total Sum of Squares31697.2T

CannBioRx Non Current Assets Total History

20241.5 M
20231.6 M
202210.7 M
202151.5 M
202051.5 M
201951.1 M
2018118.2 M

About CannBioRx Life Financial Statements

CannBioRx Life investors use historical fundamental indicators, such as CannBioRx Life's Non Current Assets Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CannBioRx Life. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total1.6 M1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.